A useful Haematococcus pluvialis powder COA should match the delivered lot and exact ingredient form, then report the relevant test methods, results, units, reporting basis, dates, and acceptance criteria. For an HPLC astaxanthin assay, QA should also be able to establish what was measured and how the sample was prepared. A COA supports a defined receiving decision; it cannot establish suitability for every market, application, or finished formula.
Cover image: AI-generated illustrative scene: match the document to the exact ingredient and delivered lot.
At AimGrow, we recommend reviewing the batch document alongside the approved product specification and the intended use. This guide is for quality assurance, laboratory, and procurement teams evaluating incoming material. It does not present an AimGrow batch result or a universal specification.
1. Does the COA match the material you received?
Start with identity and traceability before comparing an assay number. Whole algal biomass, disrupted-cell powder, an extracted oleoresin, and a carrier-based powder are different materials. A report for one form should not be used to release another simply because both names contain “astaxanthin.” For a formulation comparison, see our guide to biomass powder and oleoresin forms.
| Document field | Receiving-team check |
|---|---|
| Product identity and form | Match the species, product code, processing description, and declared carriers or oils to the ordered material. |
| Lot and sample identifiers | Match the COA lot to container labels and shipment records. Link any laboratory sample or report number to that lot. |
| Specification reference | Check the approved specification and revision. Distinguish an agreed acceptance limit from a typical informational value. |
| Dates and document control | Identify manufacture, sampling, testing, report issue, and any retest or expiry dates as applicable; clarify missing dates and revisions. |
| Results and methods | Review the stated method, units, numerical results where applicable, qualitative findings, and acceptance criteria for each reported test. |
| Issuing and reviewing parties | Identify who issued the COA, which laboratory performed the work where relevant, and how the report can be authenticated. |
A specification defines the acceptance criteria. A lot-specific COA reports findings for the material it identifies. An underlying laboratory report or method summary may provide details that the short COA omits. Keep these documents linked rather than treating them as interchangeable.
An issue date alone does not establish sample freshness or continuing stability. Check when the sample was taken and tested, the material's storage history, and the basis for any retest or expiry period. Do not substitute a different lot's report for an unexplained gap.
2. How should QA review the HPLC astaxanthin assay?
For a Haematococcus pluvialis powder COA, “HPLC” identifies an analytical technique. It does not fully describe the extraction, chromatographic measurement, calibration, or calculation. Request the method identifier and version, then clarify the following points.
What does “total astaxanthin” mean?
Ask whether the result describes free astaxanthin, specified isomers, esterified material, or a defined total. If esters are hydrolyzed before measurement, establish how the result is calculated and expressed. The mass of astaxanthin esters and an astaxanthin-equivalent mass are different reporting concepts. The COA, specification, and method should use a consistent definition.
A 2010 primary study of health foods evaluated HPLC quantification after enzymatic hydrolysis of esterified astaxanthin. It illustrates why sample preparation and the definition of the analyte belong in an assay review; its validation in those products is not automatic validation for every commercial powder.
How was the sample prepared?
Request a suitable method summary covering representative sampling, homogenization or cell disruption where relevant, extraction, any hydrolysis or saponification, dilution, and protection during handling. Confirm that the procedure can recover and measure the declared analyte in the actual material, including its carrier matrix.
A primary Haematococcus quantification study compared pretreatment approaches and reported different measurements after enzymatic and alkaline treatment. The practical point is to examine preparation and recovery before comparing results from two laboratories. It is not a reason to prescribe one preparation procedure for all grades.
What supports the calibration and method performance?
Ask which reference standard was used, how its identity and purity were established, and which isomers or peaks are included in the calculation. Review method suitability for the sample matrix and concentration range, including relevant evidence for specificity, accuracy or recovery, precision, and robustness. Clarify material method changes before accepting a historical comparison.
A 2022 method-development study investigated sample preparation, enzymolysis, calibration, handling, and UHPLC quantification across astaxanthin-containing materials. It also compared photometric estimates with chromatographic results. This supports reviewing the complete procedure. A UV/VIS estimate and an HPLC result should not be treated as interchangeable without evidence that they are suitable and comparable for the intended decision.
Are the units and reporting basis comparable?
Check whether the assay is reported as percent by mass, mg/g, or mg/kg, and whether the denominator is the material as supplied or its dry mass. For arithmetic only, 1% w/w equals 10 mg/g. That example is not an AimGrow specification or a recommended use level.
A dry-basis result should not be compared directly with an as-supplied limit without the appropriate moisture information and agreed calculation. Also distinguish pigment concentration in a prepared analytical solution from content in the original powder. Ask the laboratory to clarify the reported basis before using the result in a release or formulation calculation.
Do the result and acceptance limit answer the same question?
Compare like analytes, methods, units, and bases. A method's detection or quantification limit is different from the product's acceptance limit. A “not detected” finding needs its analytical scope and reporting threshold; it is not a numerical zero. Resolve rounding, ambiguous symbols, or conflicting report versions through the responsible quality team.
3. Which contaminant tests belong in the review?
Select the panel from the ingredient and production process, destination market, intended use, and applicable requirements. A whole-biomass powder and a formulated extract may need different supporting information. The panel and its limits should be documented in the relevant specification or quality plan.
FDA's HACCP principles describe assessing hazards in relation to ingredients, processing, storage, distribution, intended use, and consumers. That is a useful risk-assessment framework, not a universal Haematococcus test list.
- Microbiological findings: determine the relevant organisms, indicator counts, test portions, methods, and acceptance criteria for the material and its intended use. Confirm what an absence result actually covers.
- Elements: review the individual analytes and any required chemical form, units, and reporting thresholds. FDA identifies arsenic, lead, mercury, and cadmium among environmental contaminants. This does not establish one set of limits for every algae ingredient or market.
- Process and source-related residues: evaluate whether cultivation inputs, extraction solvents, processing aids, or other identified risks call for specific tests or supporting controls. Define the analytes instead of relying on an unspecified “residue-free” statement.
- Carriers, allergens, and other relevant risks: consider the actual composition and manufacturing context. Address any identified natural-toxin or cross-contamination risk with a documented scope; do not assume that every material requires the same panel.
The reviewed information should explain why the chosen criteria fit the application. Passing the listed tests does not establish that unlisted hazards were assessed, that a different serving level is suitable, or that the finished product is stable. Review legal ingredient use and finished-product requirements separately.
Can a supplier COA replace incoming verification?
That depends on the applicable rules and the manufacturer's quality system. For U.S. dietary-supplement manufacturing, FDA's Part 111 compliance guide distinguishes dietary-ingredient identity testing from reliance on supplier COAs for other component specifications. It describes supplier qualification, confirmation of COA reliability, method descriptions, limits and actual results, periodic reconfirmation, and quality-control review. Do not assume a COA replaces required identity testing. Other markets and product categories need their own review.
What should procurement send for a useful quality review?
Provide the ordered product code and form, delivered lot and shipment information, approved specification, COA and associated reports, destination market, intended application, and proposed use level. List the precise gaps: an unmatched lot, unclear assay basis, absent method reference, missing threshold, or conflicting dates. Follow the receiving procedure for material awaiting a disposition decision.
Contact AimGrow with the ingredient form, intended market and use, and the specification, document, or sample information you need. Ask which current material and supporting documentation are available for review against that brief.
The receiving decision should connect the lot, the approved specification, and suitable evidence for the intended application. No single COA establishes every possible use. A clear, documented review makes discrepancies easier to resolve before material enters a formulation or manufacturing process.
Sources reviewed October 12, 2026. Images are AI-generated illustrative scenes of document review and laboratory work, not AimGrow facilities, real COAs, chromatograms, or measured batch results.